MorphoSys Establishes ADR Level One Program in USA
News Jan 11, 2006
Morphosys AG has announced the launch of a sponsored ADR (American Depository Receipt) Program Level I in order to support broadening the Company's US investor base.
The trading symbol for MorphoSys's ADR is MPSYY and its CUSIP number is 617760103.
Each MorphoSys ADR represents one MorphoSys ordinary share as traded on the Frankfurt Stock Exchange.
MorphoSys has appointed The Bank of New York as the depositary bank for its ADR Program.
"The launch of our ADR Program is intended to increase access to the U.S. capital markets, and enhance the trading options for existing and potential new investors," commented Dave Lemus, Chief Financial Officer of MorphoSys.
Neural Inflammation Critical for Stress-Induced DepressionNews
Researchers have discovered that neural inflammation caused by our innate immune system plays an unexpectedly important role in stress-induced depression.READ MORE
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.
15th International Conference and Exhibition on Metabolomics & Systems
Apr 29 - Apr 30, 2019